Nuvation Bio Inc. — Institutional Ownership
Which tracked institutions hold NUVB, and how they changed the position last quarter. Latest holdings as of Mar 31, 2026. Source: SEC 13-F filings.
24
Funds holding
$194500704
Total value held
Buying
19 added/new · 4 reduced
| # | Institution | Value | Shares | Δ Shares | Change (QoQ) |
|---|---|---|---|---|---|
| 1 | Blackrock, Inc. | $107680605 | 25100374 | +430598 | +1.75% |
| 2 | State Street Corp | $29107337 | 6784927 | +926145 | +15.81% |
| 3 | Bank Of America Corp /De/ | $13813054 | 3219826 | -589599 | -15.48% |
| 4 | Invesco Ltd. | $10618881 | 1185143 | +687597 | +138.20% |
| 5 | Northern Trust Corp | $8593333 | 2003108 | +81376 | +4.23% |
| 6 | Goldman Sachs Group Inc | $8279498 | 1929953 | +233940 | +13.79% |
| 7 | Morgan Stanley | $8027522 | 1871217 | +595089 | +46.63% |
| 8 | Bank Of New York Mellon Corp | $2932204 | 683497 | -3731 | -0.54% |
| 9 | Wells Fargo & Company/Mn | $2436556 | 271937 | +82595 | +43.62% |
| 10 | Citigroup Inc | $565215 | 63082 | -859815 | -93.16% |
| 11 | Franklin Resources Inc | $508764 | 118593 | +118409 | +64352.72% |
| 12 | Barclays Plc | $491166 | 114491 | — | NEW BUY |
| 13 | Janus Henderson Group Plc | $463410 | 108400 | — | NEW BUY |
| 14 | Raymond James Financial Inc | $270013 | 62940 | +2269 | +3.74% |
| 15 | M&T Bank Corp | $210882 | 23578 | — | NEW BUY |
| 16 | Sei Investments Co | $185341 | 43203 | — | NEW BUY |
| 17 | Prudential Financial Inc | $158859 | 37030 | +22740 | +159.13% |
| 18 | Principal Financial Group Inc | $48177 | 11230 | +531 | +4.96% |
| 19 | Atlantic Union Bankshares Corp | $44800 | 5000 | — | Held |
| 20 | Pnc Financial Services Group, Inc. | $37855 | 8824 | -521 | -5.58% |
| 21 | Royal Bank Of Canada | $20000 | 4654 | — | NEW BUY |
| 22 | Us Bancorp \De\ | $6782 | 1581 | +106 | +7.19% |
| 23 | Fifth Third Bancorp | $319 | 74 | — | NEW BUY |
| 24 | Amalgamated Financial Corp. | $131 | 24816 | — | NEW BUY |
Aggregated across tracked institutional filers. Reported quarterly on SEC Form 13-F and may lag. For research only — not investment advice.